Study Probes Best Choice of Drug to Reduce Phosphate in Patients on Dialysis.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 298, n. 17, p. 1995, doi. 10.1001/jama.298.17.1995
- By:
- Publication type:
- Article
Works matching DE "GENZYME Corp."
Results: 85
1
2
A united front.
- Published in:
- 2011
- Publication type:
- Editorial
3
Genzyme deal set to alter biotech landscape.
- Published in:
- Nature, 2011, v. 470, n. 7335, p. 449, doi. 10.1038/470449a
- By:
- Publication type:
- Article
4
Seven days: 28 January?3 February 2011.
- Published in:
- Nature, 2011, v. 470, n. 7332, p. 10, doi. 10.1038/470010a
- Publication type:
- Article
5
News briefing: 3 June 2010.
- Published in:
- Nature, 2010, v. 465, n. 7298, p. 530, doi. 10.1038/465530a
- Publication type:
- Article
6
Billion-dollar bid for stem-cell treatments.
- Published in:
- Nature, 2008, v. 456, n. 7219, p. 153, doi. 10.1038/456153c
- Publication type:
- Article
7
Teriflunomide approved by the US FDA.
- Published in:
- Expert Review of Clinical Pharmacology, 2012, v. 5, n. 6, p. 615, doi. 10.1586/ECP.12.67
- By:
- Publication type:
- Article
8
Adopting Solutions to Orphan Drug Shortages.
- Published in:
- U.C. Davis Law Review, 2015, v. 48, n. 5, p. 2077
- By:
- Publication type:
- Article
9
Adventitious Viral Contamination of Biopharmaceuticals: Who is at Risk?
- Published in:
- BioProcessing Journal, 2011, v. 10, n. 1, p. 4, doi. 10.12665/J101.Nims
- By:
- Publication type:
- Article
10
Sanofi-Aventis' hostile bid for Genzyme.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 833, p. 11
- Publication type:
- Article
11
Genzyme rejects Sanofi, sells genetic testing.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 832, p. 8
- Publication type:
- Article
12
Genzyme admits more Boston problems.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 819, p. 11
- Publication type:
- Article
13
Vesivirus return shuts Genzyme plant.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 817/818, p. 12
- Publication type:
- Article
14
Banking on the future: Biobanking human blood and tissue advances cancer research.
- Published in:
- 2014
- By:
- Publication type:
- Other
15
Timeline of events: A brief history of what made news this year.
- Published in:
- Nature Medicine, 2011, v. 17, n. 12, p. 1543, doi. 10.1038/nm1211-1543
- Publication type:
- Article
16
March on, not in.
- Published in:
- 2011
- Publication type:
- Editorial
17
NIH faces marching orders on orphan drug shortage.
- Published in:
- Nature Medicine, 2011, v. 17, n. 5, p. 522, doi. 10.1038/nm0511-522b
- By:
- Publication type:
- Article
18
Genzyme, though unique, could be a bellwether for US biotech.
- Published in:
- Nature Medicine, 2011, v. 17, n. 2, p. 145, doi. 10.1038/nm0211-145
- By:
- Publication type:
- Article
19
Pharmaceutical; trademark; patents; news.
- Published in:
- Journal of Generic Medicines, 2011, v. 8, n. 2, p. 117, doi. 10.1177/1741134311413530
- By:
- Publication type:
- Article
20
News Blast.
- Published in:
- Bio-IT World, 2006, v. 5, n. 2, p. 24
- Publication type:
- Article
21
Guerilla Informatics -- Genzyme Style.
- Published in:
- Bio-IT World, 2006, v. 5, n. 2, p. 12
- By:
- Publication type:
- Article
22
Biotech Beckons in Bonny Scotland.
- Published in:
- Bio-IT World, 2005, v. 4, n. 10, p. 46
- By:
- Publication type:
- Article
23
RECOMBINATION.
- Published in:
- Bio-IT World, 2003, v. 2, n. 9, p. 22
- Publication type:
- Article
24
Drug that boosts nerve signals offers hope for multiple sclerosis.
- Published in:
- Nature, 2015, v. 520, n. 7548, p. 417, doi. 10.1038/520417a
- By:
- Publication type:
- Article
25
Technology: Investment suggests RNAi is on the up.
- Published in:
- Nature, 2014, v. 510, n. 7503, p. 35, doi. 10.1038/510035b
- By:
- Publication type:
- Article
26
Acknowledgements.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_9, p. ix63, doi. 10.1093/ndt/gfm803
- Publication type:
- Article
27
Market watch: Upcoming market catalysts in Q4 2011.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 10, p. 723, doi. 10.1038/nrd3564
- By:
- Publication type:
- Article
28
Regulatory Affairs.
- Published in:
- 2009
- Publication type:
- Interview
29
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 6, p. 466, doi. 10.1038/nrd2611
- Publication type:
- Article
30
Joanna F. Haas.
- Published in:
- 2005
- Publication type:
- Interview
31
Patent Watch.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 9, p. 690, doi. 10.1038/nrd1188
- Publication type:
- Article
32
Society News.
- Published in:
- American Journal of Sports Medicine, 2010, v. 38, n. 4, p. 842, doi. 10.1177/0363546510368053
- Publication type:
- Article
33
New therapy for rare metabolic disorder Pompe disease approved by US FDA.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2010, v. 5, n. 4, p. 479, doi. 10.1586/EEM.10.43
- Publication type:
- Article
34
Co-Defense and Attack on Clinical Trials.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 11, p. 28
- By:
- Publication type:
- Article
35
Gaucher's disease oral therapy gets nod from FDA.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 970, doi. 10.1038/nbt1014-970
- By:
- Publication type:
- Article
36
Markets, venture investors and big pharma interest in RNAi soars.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 3, p. 203, doi. 10.1038/nbt0314-203
- By:
- Publication type:
- Article
37
Shire drops 'emergency' Fabry's disease drug.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 6, p. 478, doi. 10.1038/nbt0612-478c
- By:
- Publication type:
- Article
38
New drugs and dosage forms.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. 18, p. 1599
- Publication type:
- Article
39
€130M GENZYME EXPANSION SHOWS CONFIDENCE IN BIOPHARMA SECTOR.
- Published in:
- Engineers Journal, 2009, v. 63, n. 7, p. 346
- By:
- Publication type:
- Article
40
At last: Genzyme falls to sanofi aventis.
- Published in:
- Chemistry & Industry, 2011, n. 5, p. 5
- By:
- Publication type:
- Article
41
Genzyme faces $175m FDA fines.
- Published in:
- Chemistry & Industry, 2010, n. 9, p. 5
- By:
- Publication type:
- Article
42
News in brief.
- Published in:
- Chemistry & Industry, 2008, n. 23, p. 9
- Publication type:
- Article
43
Genzyme deal.
- Published in:
- Chemistry & Industry, 2008, n. 15, p. 5
- Publication type:
- Article
44
Business Digest.
- Published in:
- Chemistry & Industry, 2008, n. 2, p. 13
- By:
- Publication type:
- Article
45
Business Digest.
- Published in:
- Chemistry & Industry, 2007, n. 21, p. 13
- By:
- Publication type:
- Article
46
News briefs.
- Published in:
- Chemistry & Industry, 2007, n. 18, p. 6
- Publication type:
- Article
47
Business Digest.
- Published in:
- Chemistry & Industry, 2007, n. 5, p. 14
- Publication type:
- Article
48
Business Digest.
- Published in:
- Chemistry & Industry, 2006, n. 24, p. 14
- By:
- Publication type:
- Article
49
Movers & Shakers.
- Published in:
- Chemistry & Industry, 2003, n. 6, p. 30
- Publication type:
- Article
50
SPONSORS.
- Published in:
- Nephrology, 2006, v. 11, p. iv, doi. 10.1111/j.1440-1797.2006.00658_2.x
- Publication type:
- Article